As Head of AI Strategy & Innovation for R&D at AstraZeneca, Hebe leads a global department investing and building in AI across the pharmaceutical value chain for the UK’s largest company. Hebe has prior experience in deep tech, leading the Knowledge Graph department at BenevolentAI and working at the medtech company, Huma. She is a global speaker on AI-enabled drug discovery. With degrees from Oxford and Imperial College London, Hebe’s expertise in epidemiology, neuroscience is complemented by her corporate leadership in advancing pharmaceutical innovation